$363 Million is the total value of Iguana Healthcare Management, LLC's 133 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 70.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CELG | Buy | CELGENE CORP | $21,874,000 | +72.8% | 150,000 | +53.8% | 6.03% | -15.7% |
| ESPR | Buy | ESPERION THERAPEUTICS INC NE | $15,036,000 | +224.9% | 300,000 | +200.0% | 4.15% | +58.5% |
| IMMU | Buy | IMMUNOMEDICS INC | $13,980,000 | +387.1% | 1,000,000 | +207.7% | 3.86% | +137.5% |
| CLVS | Buy | CLOVIS ONCOLOGY INC | $13,184,000 | +87.8% | 160,000 | +113.3% | 3.64% | -8.4% |
| BIIB | Buy | BIOGEN INC | $12,524,000 | +515.4% | 40,000 | +433.3% | 3.45% | +200.3% |
| New | CLOVIS ONCOLOGY INCcall | $12,360,000 | – | 150,000 | +100.0% | 3.41% | – | |
| ABBV | Buy | ABBVIE INC | $11,552,000 | +298.3% | 130,000 | +225.0% | 3.18% | +94.3% |
| ALXN | Buy | ALEXION PHARMACEUTICALS INC | $11,224,000 | +53.8% | 80,000 | +33.3% | 3.10% | -25.0% |
| CI | Buy | CIGNA CORPORATION | $9,908,000 | +238.3% | 53,000 | +202.9% | 2.73% | +65.0% |
| AERI | Buy | AERIE PHARMACEUTICALS INC | $9,720,000 | +94.7% | 200,000 | +110.5% | 2.68% | -5.0% |
| MRK | Buy | MERCK & CO INC | $9,604,000 | +87.3% | 150,000 | +87.5% | 2.65% | -8.6% |
| ABT | Buy | ABBOTT LABS | $9,072,000 | +366.7% | 170,000 | +325.0% | 2.50% | +127.6% |
| AET | Buy | AETNA INC NEW | $9,064,000 | +83.7% | 57,000 | +75.4% | 2.50% | -10.4% |
| KPTI | Buy | KARYOPHARM THERAPEUTICS INC | $8,784,000 | +223.5% | 800,000 | +166.7% | 2.42% | +57.8% |
| KTWO | Buy | K2M GROUP HLDGS INC | $8,484,000 | +74.1% | 400,000 | +100.0% | 2.34% | -15.1% |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS IN | $7,762,000 | +62.2% | 250,000 | +42.9% | 2.14% | -20.9% |
| MDCO | Buy | MEDICINES CO | $7,408,000 | +29.9% | 200,000 | +33.3% | 2.04% | -36.6% |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $7,292,000 | +378.2% | 250,000 | +354.5% | 2.01% | +133.3% |
| ZBH | Buy | ZIMMER BIOMET HLDGS INC | $7,026,000 | +118.9% | 60,000 | +140.0% | 1.94% | +6.7% |
| BMY | New | BRISTOL MYERS SQUIBB CO | $7,012,000 | – | 110,000 | +100.0% | 1.93% | – |
| LLY | Buy | LILLY ELI & CO | $6,844,000 | +66.3% | 80,000 | +60.0% | 1.89% | -18.9% |
| DERM | Buy | DERMIRA INC | $6,750,000 | +65.4% | 250,000 | +78.6% | 1.86% | -19.3% |
| JUNO | Buy | JUNO THERAPEUTICS INC | $6,730,000 | +125.2% | 150,000 | +50.0% | 1.86% | +9.8% |
| GKOS | Buy | GLAUKOS CORP | $6,600,000 | +165.3% | 200,000 | +233.3% | 1.82% | +29.4% |
| TSRO | Buy | TESARO INC | $6,456,000 | +207.7% | 50,000 | +233.3% | 1.78% | +50.1% |
| DHR | New | DANAHER CORP DEL | $6,004,000 | – | 70,000 | +100.0% | 1.66% | – |
| SGMO | Buy | SANGAMO THERAPEUTICS INC | $6,000,000 | +217.1% | 400,000 | +86.0% | 1.65% | +54.6% |
| XENT | Buy | INTERSECT ENT INC | $5,608,000 | +186.6% | 180,000 | +157.1% | 1.55% | +39.8% |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL IN | $5,326,000 | +14.3% | 100,000 | +33.3% | 1.47% | -44.2% |
| XLRN | New | ACCELERON PHARMA INC | $5,224,000 | – | 140,000 | +100.0% | 1.44% | – |
| FGEN | New | FIBROGEN INC | $4,304,000 | – | 80,000 | +100.0% | 1.19% | – |
| PFE | New | PFIZER INC | $4,284,000 | – | 120,000 | +100.0% | 1.18% | – |
| CCXI | Buy | CHEMOCENTRYX INC | $4,082,000 | +74.4% | 550,000 | +120.0% | 1.13% | -14.9% |
| CBAY | Buy | CYMABAY THERAPEUTICS INC | $4,030,000 | +566.1% | 500,000 | +376.2% | 1.11% | +224.9% |
| CAH | New | CARDINAL HEALTH INC | $4,016,000 | – | 60,000 | +100.0% | 1.11% | – |
| ANAB | Buy | ANAPTYSBIO INC | $3,496,000 | +108.7% | 100,000 | +42.9% | 0.96% | +1.8% |
| ADMA | Buy | ADMA BIOLOGICS INC | $3,480,000 | +527.0% | 1,130,000 | +653.3% | 0.96% | +205.7% |
| AVXS | Buy | AVEXIS INC | $3,386,000 | +37.4% | 35,000 | +16.7% | 0.93% | -33.0% |
| ESRX | New | EXPRESS SCRIPTS HLDG CO | $3,166,000 | – | 50,000 | +100.0% | 0.87% | – |
| OMED | Buy | ONCOMED PHARMACEUTICALS INC | $3,164,000 | +137.5% | 700,000 | +75.0% | 0.87% | +15.8% |
| INSM | New | INSMED INC | $3,122,000 | – | 100,000 | +100.0% | 0.86% | – |
| RXDX | Buy | IGNYTA INC | $3,088,000 | +496.1% | 250,000 | +400.0% | 0.85% | +190.4% |
| ARNA | New | ARENA PHARMACEUTICALS INC | $3,060,000 | – | 120,000 | +100.0% | 0.84% | – |
| MRUS | Sell | MERUS N V | $2,782,000 | +0.3% | 140,000 | -20.0% | 0.77% | -51.1% |
| CORI | Buy | CORIUM INTL INC | $2,770,000 | +271.3% | 250,000 | +150.0% | 0.76% | +81.0% |
| KURA | New | KURA ONCOLOGY INC | $2,692,000 | – | 180,000 | +100.0% | 0.74% | – |
| CTMX | Buy | CYTOMX THERAPEUTICS INC | $2,544,000 | +173.5% | 140,000 | +133.3% | 0.70% | +33.3% |
| DPLO | Buy | DIPLOMAT PHARMACY INC | $2,486,000 | +124.0% | 120,000 | +60.0% | 0.68% | +9.1% |
| WVE | Buy | WAVE LIFE SCIENCES LTD | $2,392,000 | +133.8% | 110,000 | +100.0% | 0.66% | +14.2% |
| TDOC | New | TELADOC INC | $2,320,000 | – | 70,000 | +100.0% | 0.64% | – |
| ASND | New | ASCENDIS PHARMA A Ssponsored adr | $2,176,000 | – | 60,000 | +100.0% | 0.60% | – |
| MRNS | New | MARINUS PHARMACEUTICALS INC | $2,054,000 | – | 350,000 | +100.0% | 0.57% | – |
| SRRA | New | SIERRA ONCOLOGY INC | $1,860,000 | – | 1,200,000 | +100.0% | 0.51% | – |
| FOLD | New | AMICUS THERAPEUTICS INC | $1,810,000 | – | 120,000 | +100.0% | 0.50% | – |
| PRTK | New | PARATEK PHARMACEUTICALS INC | $1,758,000 | – | 70,000 | +100.0% | 0.48% | – |
| New | INCYTE CORPcall | $1,752,000 | – | 15,000 | +100.0% | 0.48% | – | |
| IONS | New | IONIS PHARMACEUTICALS INC | $1,522,000 | – | 30,000 | +100.0% | 0.42% | – |
| ZGNX | Sell | ZOGENIX INC | $1,402,000 | +13.7% | 40,000 | -52.9% | 0.39% | -44.5% |
| Buy | NEOVASC INC | $1,224,000 | +153.4% | 720,000 | +105.7% | 0.34% | +23.4% | |
| New | EXELIXIS INCput | $1,212,000 | – | 50,000 | +100.0% | 0.33% | – | |
| SCYX | Buy | SCYNEXIS INC | $1,206,000 | +199.3% | 500,000 | +122.2% | 0.33% | +46.1% |
| CTLT | New | CATALENT INC | $1,198,000 | – | 30,000 | +100.0% | 0.33% | – |
| VYGR | New | VOYAGER THERAPEUTICS INC | $1,030,000 | – | 50,000 | +100.0% | 0.28% | – |
| New | PTC THERAPEUTICS INCcall | $1,000,000 | – | 50,000 | +100.0% | 0.28% | – | |
| AKAOQ | ACHAOGEN INC | $958,000 | -26.5% | 60,000 | 0.0% | 0.26% | -64.2% | |
| New | IGNYTA INCcall | $618,000 | – | 50,000 | +100.0% | 0.17% | – | |
| ADAP | New | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $410,000 | – | 50,000 | +100.0% | 0.11% | – |
| OBSV | Buy | OBSEVA SA | $407,000 | +58.4% | 50,000 | +66.7% | 0.11% | -22.8% |
| RAD | Exit | RITE AID CORP | $0 | – | -150,000 | -100.0% | -0.25% | – |
| Exit | SANOFIcall | $0 | – | -15,000 | -100.0% | -0.41% | – | |
| XNCR | Exit | XENCOR INC | $0 | – | -40,000 | -100.0% | -0.48% | – |
| EW | Exit | EDWARDS LIFESCIENCES CORP | $0 | – | -7,500 | -100.0% | -0.50% | – |
| EPZM | Exit | EPIZYME INC | $0 | – | -75,000 | -100.0% | -0.64% | – |
| Exit | IMMUNOMEDICS INCcall | $0 | – | -150,000 | -100.0% | -0.75% | – | |
| GWPH | Exit | GW PHARMACEUTICALS PLCads | $0 | – | -15,000 | -100.0% | -0.85% | – |
| MDT | Exit | MEDTRONIC PLC | $0 | – | -20,000 | -100.0% | -1.00% | – |
| Exit | BIOMARIN PHARMACEUTICALcall | $0 | – | -25,000 | -100.0% | -1.28% | – | |
| NUVA | Exit | NUVASIVE INC | $0 | – | -35,000 | -100.0% | -1.52% | – |
| Exit | ALEXION PHARMACEUTICALS INCcall | $0 | – | -25,000 | -100.0% | -1.72% | – | |
| Exit | ASTRAZENECA PLCput | $0 | – | -100,000 | -100.0% | -1.93% | – | |
| SNY | Exit | SANOFIsponsored adr | $0 | – | -75,000 | -100.0% | -2.03% | – |
| Exit | CLOVIS ONCOLOGY INCput | $0 | – | -40,000 | -100.0% | -2.12% | – | |
| SPNC | Exit | SPECTRANETICS CORP | $0 | – | -110,000 | -100.0% | -2.39% | – |
| AGN | Exit | ALLERGAN PLC | $0 | – | -25,000 | -100.0% | -3.44% | – |
| Exit | MERCK & CO INCcall | $0 | – | -100,000 | -100.0% | -3.62% | – | |
| SHPG | Exit | SHIRE PLCsponsored adr | $0 | – | -40,000 | -100.0% | -3.74% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOGEN INC | 17 | Q1 2018 | 7.5% |
| ULTRAGENYX PHARMACEUTICAL IN | 17 | Q1 2018 | 6.7% |
| MERCK & CO INC NEW | 16 | Q1 2018 | 5.4% |
| CELGENE CORP | 15 | Q4 2017 | 7.9% |
| AERIE PHARMACEUTICALS INC | 15 | Q4 2017 | 3.3% |
| GILEAD SCIENCES INC | 14 | Q1 2017 | 6.7% |
| ESPERION THERAPEUTICS INC NE | 14 | Q1 2018 | 7.8% |
| SUPERNUS PHARMACEUTICALS INC | 14 | Q4 2017 | 2.8% |
| DERMIRA INC | 14 | Q1 2018 | 2.7% |
| AMGEN INC | 13 | Q1 2017 | 6.5% |
View Iguana Healthcare Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2018-05-15 |
| 13F-HR | 2018-02-14 |
| 13F-HR/A | 2017-11-16 |
| 13F-HR | 2017-11-14 |
| 13F-HR | 2017-08-14 |
| 13F-HR | 2017-05-15 |
| 13F-HR | 2017-02-14 |
| 13F-HR/A | 2016-11-17 |
| 13F-HR | 2016-11-14 |
| 13F-HR/A | 2016-11-04 |
View Iguana Healthcare Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.